ID   ACKR3_RAT               Reviewed;         362 AA.
AC   O89039; Q9JLZ0;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   25-JAN-2012, sequence version 2.
DT   29-MAY-2024, entry version 159.
DE   RecName: Full=Atypical chemokine receptor 3 {ECO:0000305};
DE   AltName: Full=C-X-C chemokine receptor type 7;
DE            Short=CXC-R7;
DE            Short=CXCR-7;
DE   AltName: Full=Chemokine orphan receptor 1;
DE   AltName: Full=G-protein coupled receptor RDC1 homolog;
DE            Short=RDC-1;
GN   Name=Ackr3 {ECO:0000312|RGD:620601}; Synonyms=Cmkor1, Cxcr7, Rdc1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Lung;
RA   Mirtella A., Lowe S.R., Bartlett T.J., Drake W., Clark A.J.;
RT   "Investigation of the role of rat RDC-1 as a putative calcitonin gene-
RT   related peptide receptor.";
RL   Submitted (SEP-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Muscle;
RA   Xie P., Fu A.K.Y., Ip N.Y.;
RL   Submitted (JAN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=18615560; DOI=10.1002/cne.21780;
RA   Schonemeier B., Kolodziej A., Schulz S., Jacobs S., Hoellt V., Stumm R.;
RT   "Regional and cellular localization of the CXCl12/SDF-1 chemokine receptor
RT   CXCR7 in the developing and adult rat brain.";
RL   J. Comp. Neurol. 510:207-220(2008).
RN   [5]
RP   TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=18513805; DOI=10.1016/j.jneuroim.2008.04.010;
RA   Schonemeier B., Schulz S., Hoellt V., Stumm R.;
RT   "Enhanced expression of the CXCl12/SDF-1 chemokine receptor CXCR7 after
RT   cerebral ischemia in the rat brain.";
RL   J. Neuroimmunol. 198:39-45(2008).
RN   [6]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=20018651; DOI=10.1073/pnas.0912852107;
RA   Rajagopal S., Kim J., Ahn S., Craig S., Lam C.M., Gerard N.P., Gerard C.,
RA   Lefkowitz R.J.;
RT   "Beta-arrestin- but not G protein-mediated signaling by the 'decoy'
RT   receptor CXCR7.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:628-632(2010).
RN   [7]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=21655198; DOI=10.1371/journal.pone.0020680;
RA   Shimizu S., Brown M., Sengupta R., Penfold M.E., Meucci O.;
RT   "CXCR7 protein expression in human adult brain and differentiated
RT   neurons.";
RL   PLoS ONE 6:E20680-E20680(2011).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-350, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Atypical chemokine receptor that controls chemokine levels
CC       and localization via high-affinity chemokine binding that is uncoupled
CC       from classic ligand-driven signal transduction cascades, resulting
CC       instead in chemokine sequestration, degradation, or transcytosis. Also
CC       known as interceptor (internalizing receptor) or chemokine-scavenging
CC       receptor or chemokine decoy receptor. Acts as a receptor for chemokines
CC       CXCL11 and CXCL12/SDF1. Chemokine binding does not activate G-protein-
CC       mediated signal transduction but instead induces beta-arrestin
CC       recruitment, leading to ligand internalization and activation of MAPK
CC       signaling pathway. Required for regulation of CXCR4 protein levels in
CC       migrating interneurons, thereby adapting their chemokine
CC       responsiveness. In glioma cells, transduces signals via MEK/ERK
CC       pathway, mediating resistance to apoptosis. Promotes cell growth and
CC       survival. Not involved in cell migration, adhesion or proliferation of
CC       normal hematopoietic progenitors but activated by CXCL11 in malignant
CC       hemapoietic cells, leading to phosphorylation of ERK1/2 (MAPK3/MAPK1)
CC       and enhanced cell adhesion and migration. Plays a regulatory role in
CC       CXCR4-mediated activation of cell surface integrins by CXCL12. Required
CC       for heart valve development. {ECO:0000269|PubMed:20018651}.
CC   -!- FUNCTION: Atypical chemokine receptor that controls chemokine levels
CC       and localization via high-affinity chemokine binding that is uncoupled
CC       from classic ligand-driven signal transduction cascades, resulting
CC       instead in chemokine sequestration, degradation, or transcytosis. Also
CC       known as interceptor (internalizing receptor) or chemokine-scavenging
CC       receptor or chemokine decoy receptor. Acts as a receptor for chemokines
CC       CXCL11 and CXCL12/SDF1 (By similarity). Chemokine binding does not
CC       activate G-protein-mediated signal transduction but instead induces
CC       beta-arrestin recruitment, leading to ligand internalization and
CC       activation of MAPK signaling pathway (PubMed:20018651). Required for
CC       regulation of CXCR4 protein levels in migrating interneurons, thereby
CC       adapting their chemokine responsiveness. In glioma cells, transduces
CC       signals via MEK/ERK pathway, mediating resistance to apoptosis.
CC       Promotes cell growth and survival. Not involved in cell migration,
CC       adhesion or proliferation of normal hematopoietic progenitors but
CC       activated by CXCL11 in malignant hemapoietic cells, leading to
CC       phosphorylation of ERK1/2 (MAPK3/MAPK1) and enhanced cell adhesion and
CC       migration. Plays a regulatory role in CXCR4-mediated activation of cell
CC       surface integrins by CXCL12. Required for heart valve development.
CC       Regulates axon guidance in the oculomotor system through the regulation
CC       of CXCL12 levels (By similarity). {ECO:0000250|UniProtKB:P25106,
CC       ECO:0000269|PubMed:20018651}.
CC   -!- SUBUNIT: Homodimer. Can form heterodimers with CXCR4;
CC       heterodimerization may regulate CXCR4 signaling activity. Interacts
CC       with ARRB1 and ARRB2. {ECO:0000250|UniProtKB:P25106}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:21655198};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:21655198}. Early
CC       endosome {ECO:0000305|PubMed:21655198}. Recycling endosome
CC       {ECO:0000305|PubMed:21655198}. Note=Predominantly localizes to
CC       endocytic vesicles, and upon stimulation by the ligand is internalized
CC       via clathrin-coated pits in a beta-arrestin -dependent manner. Once
CC       internalized, the ligand dissociates from the receptor, and is targeted
CC       to degradation while the receptor is recycled back to the cell membrane
CC       (By similarity). {ECO:0000250|UniProtKB:P25106}.
CC   -!- TISSUE SPECIFICITY: Expressed in vascular smooth muscle cells (at
CC       protein level). In brain, expressed in blood vessels, pyramidal cells
CC       in hippocampal subfield CA3, mature dentate gyrus granule cells,
CC       ventricle walls, olfactory bulb, accumbens shell, supraoptic,
CC       lateroanterior and ventromedial hypothalamic nuclei, medial region of
CC       thalamus, and motor nuclei, central gray and raphe magnus nucleus of
CC       brain stem. Detected in primary neurons, GABAergic neurons, astrocytes,
CC       cerebral cortex, ventral striatum and choroid plexus. Not detected in
CC       mesencephalon. {ECO:0000269|PubMed:18513805,
CC       ECO:0000269|PubMed:18615560, ECO:0000269|PubMed:20018651,
CC       ECO:0000269|PubMed:21655198}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in the ventral and dorsal parts of
CC       telencephalon at all developmental stages of brain analyzed (14 dpc to
CC       P56). Strong expression detected in the cranial connective tissue
CC       surrounding the brain at 14 dpc to 15 dpc. In the cortex, expressed
CC       mainly in the marginal zone at preplate stage (14 dpc), with expression
CC       increasing strongly in the marginal zone/layer I between 15 dpc and 18
CC       dpc and declining rapidly in layer I after P0. Expression emerges in
CC       the lateral part of cortical plate at 15 dpc and increases in the
CC       medial and lateral parts between 15 dpc and 17 dpc. Expression not
CC       detected in the cortical ventricular and subventricular zones at the
CC       early embryonic stages but emerges at 18 dpc. Expressed in GABAergic
CC       precursors and in some reelin-expressing Cajal-Ratzius cells, in
CC       neurons forming the cortical plate and sparsely in the developing
CC       dentate gyrus and cerebellar external germinal layer. In the ventral
CC       telencephalon, expressed in the germinative zone of the ganglionic
CC       eminences and in GABAergic neurons forming the caudate putamen between
CC       14 dpc and 18 dpc. {ECO:0000269|PubMed:18615560}.
CC   -!- INDUCTION: By ischemia. Up-regulated in the cingulate, retrosplenial
CC       and frontal areas of the cortex ipsilateral to middle cerebral artery
CC       occlusion (MCAO) by 163% at 6 hours, 220% at 2 days and 89% at 4 days
CC       after ischemia-onset, with expression reduced back to control level at
CC       10 days after MCAO. Expression is almost undetectable in the infarct
CC       area between days 2 and 10 after MCAO. {ECO:0000269|PubMed:18513805}.
CC   -!- DOMAIN: The C-terminal cytoplasmic tail, plays a key role in: correct
CC       trafficking to the cell membrane, recruitment of beta-arrestin,
CC       ubiquitination, and in chemokine scavenging and signaling functions.
CC       The Ser/Thr residues and the Lys residues in the C-terminal cytoplasmic
CC       tail are essential for beta-arrestin recruitment and ubiquitination
CC       respectively. {ECO:0000250|UniProtKB:P25106}.
CC   -!- PTM: The Ser/Thr residues in the C-terminal cytoplasmic tail may be
CC       phosphorylated. {ECO:0000250|UniProtKB:P25106}.
CC   -!- PTM: Ubiquitinated at the Lys residues in its C-terminal cytoplasmic
CC       tail and is essential for correct trafficking from and to the cell
CC       membrane. Deubiquitinated by CXCL12-stimulation in a reversible manner.
CC       {ECO:0000250|UniProtKB:P25106}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       Atypical chemokine receptor subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ010828; CAA09370.1; -; mRNA.
DR   EMBL; AF118816; AAF34338.1; -; mRNA.
DR   EMBL; CH473997; EDL92073.1; -; Genomic_DNA.
DR   EMBL; CH473997; EDL92074.1; -; Genomic_DNA.
DR   RefSeq; NP_445804.1; NM_053352.1.
DR   RefSeq; XP_006245541.1; XM_006245479.3.
DR   AlphaFoldDB; O89039; -.
DR   SMR; O89039; -.
DR   IntAct; O89039; 2.
DR   STRING; 10116.ENSRNOP00000026558; -.
DR   BindingDB; O89039; -.
DR   ChEMBL; CHEMBL4739671; -.
DR   GuidetoPHARMACOLOGY; 80; -.
DR   GlyCosmos; O89039; 2 sites, No reported glycans.
DR   GlyGen; O89039; 2 sites.
DR   iPTMnet; O89039; -.
DR   PhosphoSitePlus; O89039; -.
DR   PaxDb; 10116-ENSRNOP00000026558; -.
DR   Ensembl; ENSRNOT00000026558.4; ENSRNOP00000026558.2; ENSRNOG00000019622.4.
DR   Ensembl; ENSRNOT00000098919.1; ENSRNOP00000091223.1; ENSRNOG00000019622.4.
DR   Ensembl; ENSRNOT00000108608.1; ENSRNOP00000094961.1; ENSRNOG00000019622.4.
DR   Ensembl; ENSRNOT00000113813.1; ENSRNOP00000088201.1; ENSRNOG00000019622.4.
DR   Ensembl; ENSRNOT00000115723.1; ENSRNOP00000086994.1; ENSRNOG00000019622.4.
DR   Ensembl; ENSRNOT00000116518.1; ENSRNOP00000083985.1; ENSRNOG00000019622.4.
DR   Ensembl; ENSRNOT00055017132; ENSRNOP00055013784; ENSRNOG00055010155.
DR   Ensembl; ENSRNOT00055017135; ENSRNOP00055013787; ENSRNOG00055010155.
DR   Ensembl; ENSRNOT00055017137; ENSRNOP00055013789; ENSRNOG00055010155.
DR   Ensembl; ENSRNOT00055017144; ENSRNOP00055013796; ENSRNOG00055010155.
DR   Ensembl; ENSRNOT00055017145; ENSRNOP00055013797; ENSRNOG00055010155.
DR   Ensembl; ENSRNOT00060017945; ENSRNOP00060013949; ENSRNOG00060010605.
DR   Ensembl; ENSRNOT00060017948; ENSRNOP00060013953; ENSRNOG00060010605.
DR   Ensembl; ENSRNOT00060017956; ENSRNOP00060013961; ENSRNOG00060010605.
DR   Ensembl; ENSRNOT00060017958; ENSRNOP00060013963; ENSRNOG00060010605.
DR   Ensembl; ENSRNOT00060017959; ENSRNOP00060013964; ENSRNOG00060010605.
DR   Ensembl; ENSRNOT00065033508; ENSRNOP00065026799; ENSRNOG00065019894.
DR   Ensembl; ENSRNOT00065033514; ENSRNOP00065026806; ENSRNOG00065019894.
DR   Ensembl; ENSRNOT00065033517; ENSRNOP00065026809; ENSRNOG00065019894.
DR   Ensembl; ENSRNOT00065033532; ENSRNOP00065026824; ENSRNOG00065019894.
DR   Ensembl; ENSRNOT00065033543; ENSRNOP00065026833; ENSRNOG00065019894.
DR   GeneID; 84348; -.
DR   KEGG; rno:84348; -.
DR   UCSC; RGD:620601; rat.
DR   AGR; RGD:620601; -.
DR   CTD; 57007; -.
DR   RGD; 620601; Ackr3.
DR   eggNOG; KOG3656; Eukaryota.
DR   GeneTree; ENSGT01110000267168; -.
DR   HOGENOM; CLU_009579_8_3_1; -.
DR   InParanoid; O89039; -.
DR   OMA; SLVHCCI; -.
DR   OrthoDB; 5353045at2759; -.
DR   TreeFam; TF333489; -.
DR   Reactome; R-RNO-380108; Chemokine receptors bind chemokines.
DR   Reactome; R-RNO-418594; G alpha (i) signalling events.
DR   PRO; PR:O89039; -.
DR   Proteomes; UP000002494; Chromosome 9.
DR   Proteomes; UP000234681; Chromosome 9.
DR   Bgee; ENSRNOG00000019622; Expressed in esophagus and 20 other cell types or tissues.
DR   GO; GO:0009986; C:cell surface; ISS:UniProtKB.
DR   GO; GO:0005905; C:clathrin-coated pit; ISS:UniProtKB.
DR   GO; GO:0005769; C:early endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005768; C:endosome; ISS:UniProtKB.
DR   GO; GO:0009897; C:external side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0055037; C:recycling endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0019957; F:C-C chemokine binding; IBA:GO_Central.
DR   GO; GO:0016493; F:C-C chemokine receptor activity; IBA:GO_Central.
DR   GO; GO:0019958; F:C-X-C chemokine binding; ISS:UniProtKB.
DR   GO; GO:0016494; F:C-X-C chemokine receptor activity; ISO:RGD.
DR   GO; GO:0015026; F:coreceptor activity; IEA:InterPro.
DR   GO; GO:0005044; F:scavenger receptor activity; ISS:UniProtKB.
DR   GO; GO:0001525; P:angiogenesis; IEA:InterPro.
DR   GO; GO:0019722; P:calcium-mediated signaling; IBA:GO_Central.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0060326; P:cell chemotaxis; IBA:GO_Central.
DR   GO; GO:0070098; P:chemokine-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0006955; P:immune response; IBA:GO_Central.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:1902230; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; ISO:RGD.
DR   GO; GO:0021557; P:oculomotor nerve development; ISS:UniProtKB.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IBA:GO_Central.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISS:UniProtKB.
DR   GO; GO:1905322; P:positive regulation of mesenchymal stem cell migration; IMP:RGD.
DR   GO; GO:0031623; P:receptor internalization; ISS:UniProtKB.
DR   GO; GO:0001570; P:vasculogenesis; IEA:InterPro.
DR   CDD; cd14987; 7tmA_ACKR3_CXCR7; 1.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1.
DR   InterPro; IPR001416; ACKR3.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   InterPro; IPR047143; GPER1-like.
DR   PANTHER; PTHR24226; G-PROTEIN COUPLED RECEPTOR 182 AND ESTROGEN RECEPTOR 1; 1.
DR   PANTHER; PTHR24226:SF4; G_PROTEIN_RECEP_F1_2 DOMAIN-CONTAINING PROTEIN; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PRINTS; PR00646; RDC1ORPHANR.
DR   SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Cell adhesion; Cell membrane; Developmental protein; Disulfide bond;
KW   Endosome; G-protein coupled receptor; Glycoprotein; Membrane;
KW   Phosphoprotein; Receptor; Reference proteome; Transducer; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   CHAIN           1..362
FT                   /note="Atypical chemokine receptor 3"
FT                   /id="PRO_0000070103"
FT   TOPO_DOM        1..47
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        48..68
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        69..81
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        82..102
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        103..118
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        119..139
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        140..162
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        163..183
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        184..213
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        214..234
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        235..252
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        253..273
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        274..296
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        297..319
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        320..362
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          324..362
FT                   /note="C-terminal cytoplasmic tail"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         347
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P56485"
FT   MOD_RES         350
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         355
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P56485"
FT   CARBOHYD        13
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        22
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        117..196
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   CONFLICT        17
FT                   /note="I -> S (in Ref. 1; CAA09370)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        161
FT                   /note="R -> L (in Ref. 1; CAA09370)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        361
FT                   /note="T -> A (in Ref. 1; CAA09370)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   362 AA;  41650 MW;  C47D1DD678697CFD CRC64;
     MDVHLFDYVE PGNYSDINWP CNSSDCIVVD TVQCPAMPNK NVLLYTLSFI YIFIFVIGMI
     ANSVVVWVNI QAKTTGYDTH CYILNLAIAD LWVVITIPVW VVSLVQHNQW PMGELTCKIT
     HLIFSINLFG SIFFLACMSV DRYLSITYFT STSSYKKKMV RRVVCVLVWL LAFFVSLPDT
     YYLKTVTSAS NNETYCRSFY PEHSIKEWLI GMELVSVILG FAVPFTIIAI FYFLLARAMS
     ASGDQEKHSS RKIIFSYVVV FLVCWLPYHF VVLLDIFSIL HYIPFTCQLE NVLFTALHVT
     QCLSLVHCCV NPVLYSFINR NYRYELMKAF IFKYSAKTGL TKLIDASRVS ETEYSALEQN
     TK
//
